Literature DB >> 7047036

The erythrocyte sedimentation rate in orthopaedic patients.

D J Schulak, J M Rayhack, F G Lippert, F R Convery.   

Abstract

The ESR, a sensitive measure of the inflammatory response, is elevated in 90% of patients who have serious orthopedic infections, e.g., discitis, septic arthritis, and hematogenous osteomyelitis. In most cases, it is sufficient to distinguish these entities from the less serious disease states, i.e., transient synovitis. After major surgical operations or extensive trauma, the ESR often increases to high levels and, if sepsis does not supervene, it returns to normal within six months. Outpatient determination of the ESR, although useless in the early detection of malignancy, is valuable in detecting inflammatory arthridities and major sepsis.

Entities:  

Mesh:

Year:  1982        PMID: 7047036

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  Is there a role for tissue biopsy in the diagnosis of periprosthetic infection?

Authors:  Geert Meermans; Fares S Haddad
Journal:  Clin Orthop Relat Res       Date:  2010-02-04       Impact factor: 4.176

2.  PMN elastase in bone and joint infections.

Authors:  K M Peters; K Koberg; T Rosendahl; H D Haubeck
Journal:  Int Orthop       Date:  1994       Impact factor: 3.075

3.  Changes in C-reactive protein and erythrocyte sedimentation rate after hip fractures.

Authors:  N Ellitsgaard; A P Andersson; K V Jensen; M Jorgensen
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

4.  Serum biomarkers in periprosthetic joint infections.

Authors:  A Saleh; J George; M Faour; A K Klika; C A Higuera
Journal:  Bone Joint Res       Date:  2018-01       Impact factor: 5.853

5.  Erythrocyte sedimentation rate and fibrinogen concentration of whole blood influences the cellular composition of platelet-rich plasma obtained from centrifugation methods.

Authors:  Wenjing Yin; Zhengliang Xu; Jiagen Sheng; Xuetao Xie; Changqing Zhang
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.